Hospital pharmacist’s roles and responsibilities with CAR-T medicines
The development and commercialization of cell therapy drugs with chimeric antigen receptor T cells (CAR-T) represent a new challenge for Spain’s hospital pharmacy. The aim of this article is to review the key aspects of these medicines and to describe the oncohematological pharmacist’s role with...
Saved in:
| Main Authors: | María Estela Moreno-Martínez, Joan Vinent-Genestar, Carmen Muñoz-Sánchez, María Josep Carreras-Soler |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-01-01
|
| Series: | Farmacia Hospitalaria |
| Subjects: | |
| Online Access: | http://www.aulamedica.es/fh/pdf/11333.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of corticosteroids on the efficacy of CD19/22 CAR-T cell therapy in pediatric patients with B-ALL: a single-center study
by: Jing Yang, et al.
Published: (2025-01-01) -
Procalcitonin level threshold and antibiotic use in patients receiving chimeric antigen receptor T-cell therapy
by: Murari Ramesh, et al.
Published: (2024-12-01) -
Regulation of CAR transgene expression to design semiautonomous CAR-T
by: Paweł Głowacki, et al.
Published: (2024-09-01) -
The impact of CD3ζ ITAM multiplicity and sequence on CAR T-cell survival and function
by: Shubhabrata Majumdar, et al.
Published: (2025-01-01) -
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
by: Eugenio Galli, et al.
Published: (2021-10-01)